Keystone Resort Floorplan

Registered Attendees
Registered attendees (and speakers, organizers, etc.) will have access to the following items from their Account page:
- Abstracts from speakers and poster sessions, including the joint meeting abstracts, available 30 days prior to the meeting
(You can edit your own abstract from My Account page as well)
NOTE: Abstract authors/submitters may choose to not have their abstract available online and in the secure mobile app until a week before the meeting.
- Full participant list, including joint meeting participants
- Printable Invoices and Invitation Letters
- Scholarship Information
- Lodging Information
Login to My Account page
- Meeting Program
- Meeting Summary
- Abstract Information
- Registration Information
- Scholarships / Awards
- Lodging / Hotels
- Travel / Transportation
- Conference Location
- Things to Do
- Services
- My Account
This meeting will be conducted in English.
All programs are subject to change. Check this site for updates.

Twitter hashtag for this meeting: #KSneuroinflam
Neural Environment in Disease: Glial Responses and Neuroinflammation (Z1)
joint with the meeting on Neurodegenerative Diseases: New Insights and Therapeutic Opportunities (Z2)Scientific Organizers: Richard Daneman, Dorothy Schafer, Michael V. Sofroniew and Vanda A. Lennon
June 16—20, 2019
Keystone Resort, Keystone, Colorado, USA
Sponsored by BioLegend, Inc.
Keystone Symposia is committed to maintaining a positive and respectful environment at its meetings. To this end, please review and comply with our policies.
DEADLINES:
*All deadlines end at 11:59 PM US Mountain Standard Time
Scholarship Deadline: Feb 13, 2019 [details]
Discounted Abstract Deadline: Feb 13, 2019 [details]
Abstract Deadline: Mar 13, 2019 [details]
Discounted Registration Deadline: Apr 16, 2019 [details]
If you have missed a deadline due to the US government shutdown, please contact our office.
Click here to view Cancellation Policy
Discounted Abstract Deadline: February 13, 2019
*All deadlines end at 11:59 PM US Mountain Standard TimeAbstract Submission Fee: 100.00 USD*
Submission by this date receives 50.00 USD discount.
*50.00 USD will be applied to Registration Fee when you register
Abstract Details: It is best to submit your abstract early. Abstract and registration spaces are limited and may fill prior to the abstract or discounted registration deadlines. Submitting an abstract does not constitute or guarantee registration.
Submitting your abstract early allows us to:
- submit your abstract to organizers to be considered for a short talk
- accept your abstract online
- include your abstract on our website and in our secure mobile app
- reserve your space at the meeting for a poster presentation.**
(The Abstract Deadline: is March 13, 2019)
Global Health Travel Award Deadline:
*All deadlines end at 11:59 PM US Mountain Standard Time
Global Health Travel Award Details:
You MUST complete your Global Health Travel Award appplication by the Global Health Travel Award Deadline
and complete the other required steps (verify your contact information and submit a recommendation letter)
to be considered for a travel award.
Click here to learn more about Global Health Travel Awards.
Scholarship Deadline: February 13, 2019
*All deadlines end at 11:59 PM US Mountain Standard Time
Scholarship Details:
You MUST submit your abstract by the Scholarship Deadline and complete the other required steps (submit a scholarship application and submit a mentor letter) to be considered for a scholarship.
Abstract Deadline: March 13, 2019
*All deadlines end at 11:59 PM US Mountain Standard Time
Abstract Submission Fee: 100.00 USD*
*50.00 USD will be applied to Registration Fee when you register
Details: It is best to submit your abstract early. Abstract and registration spaces are limited and may fill prior to the abstract or discounted registration deadline. Submitting an abstract does not constitute or guarantee registration.
Submitting your abstract by the Abstract Deadline allows us to:
- submit your abstract to organizers to be considered for a short talk
- include your abstract on our website and in our secure mobile app
- reserve your space at the meeting for a poster presentation.**
Abstracts submitted after the Abstract Deadline will NOT be considered for a short talk.
(Discounted Abstract Deadline: is February 13, 2019)
Discounted Registration Deadline: April 16, 2019
*All deadlines end at 11:59 PM US Mountain Standard Time
Registration Fee: 845.00 USD* (includes 200.00 USD discount)
Student Registration Fee: 620.00 USD* (must complete student verification form)
*Includes 50.00 USD of your abstract submission fee
After the Discounted Registration Deadline:
Registration Fee: 1045.00 USD*
Student Registration Fee: 820.00 USD* (must complete student verification form)
*Includes 50.00 USD of your abstract submission fee
Registration spaces are limited and may fill prior to discounted registration deadline.
We highly recommend that you not make a reservation with these companies or any other housing service! These companies' representations to participants have been misleading. Please report any calls or correspondence you might have received to Keystone Symposia and book only through lodging links in your Keystone Symposia account, an established travel agency or directly with the hotel(s) listed on our website.
Conference Program Print | View meeting in 12 hr (am/pm) time
The meeting will begin on Sunday, June 16 with registration from 16:00 to 20:00 and a welcome mixer from 18:00 to 20:00. Conference events conclude on Thursday, June 20 with a closing plenary session from 17:00 to 19:00, followed by a social hour and entertainment. We recommend return travel on Friday, June 21 in order to fully experience the meeting.
SUNDAY, JUNE 16
Neuron-Glia Interaction in Health and Disease
Following Session is for Neurodegenerative Diseases: New Insights and Therapeutic Opportunities (Z2)
Neural Circuits & Neuroregeneration
Gial-Neuronal Interactions in Modulating Neurodegeneration in Alzheimer’s Disease
Germinal Matrix Hemorhagge
Mechanisms of Axon Degeneration
Following Session is for Neurodegenerative Diseases: New Insights and Therapeutic Opportunities (Z2)
Amyloid Beta Organoid Model
Following Session is for Neurodegenerative Diseases: New Insights and Therapeutic Opportunities (Z2)
Following Session is for Neurodegenerative Diseases: New Insights and Therapeutic Opportunities (Z2)
Registered attendees can view abstracts starting on 05/16/2019
The Mechanism of Pathological alpha-synuclein Transmission
Prion Neurodegeneration: Towards an Effective Treatment and its Relevance for Alzheimer’s Disease
Alpha-synuclein Antibodies as Therapeutics in Aynucleinopathies – How Antibodies affect Cellular Handling of Misfolded alpha-synuclein
Astrocyte Scars do not Prevent Axon Regeneration
How Do Astrocyte-Synapse Interactions Sculpt Neural Circuits?
Astrocyte Regulation of Circuitry
Microglia Dysregulation in Multiple Sclerosis
Microglial Regulation of Alzheimer’s Disease
Talk Title to be Announced
Environmental Control of Astrocyte Proinflammatory Activities
Following Session is for Neurodegenerative Diseases: New Insights and Therapeutic Opportunities (Z2)
Antisense-based Strategies
Microglia and Neurologic Disease
Gene Silencing Therapy for Neurodegenerative Disease
Talk Title to be Announced
Following Session is for Neurodegenerative Diseases: New Insights and Therapeutic Opportunities (Z2)
Registered attendees can view abstracts starting on 05/16/2019
Preclinical Mouse Models of Neurodegenerative Diseases Spinal Muscular Atrophy (SMA), Friedreich’s Ataxia, Amyotrophic Lateral Sclerosis (ALS) and Frontotemperal Lobe Dementia (FTD)
Organiod Models of Triple Repeat Diseases
iPSC to Study Repair and Neurodegeneration
Regulation of the Blood-Brain Barrier in Health and Disease
Talk Title to be Announced
Modeling the BBB in iPSCs
Registered attendees can view abstracts starting on 05/16/2019
CNS Lymphatics
Meningeal Fibroblast Identity and Function: New Insights from scRNA-Sequencing
Following Session is for Neurodegenerative Diseases: New Insights and Therapeutic Opportunities (Z2)
Registered attendees can view abstracts starting on 05/16/2019
Therapeutic Strategies based on Human Genetics
Novel Therapeutics for Neurodegenerative Disease
Discovery and Development of LRRK2 Inhibitors
Microglial Activation States in Alzheimer's Disease
Following Session is for Neurodegenerative Diseases: New Insights and Therapeutic Opportunities (Z2)
Astrocytic and Oligodendroglial Autoimmunity
Talk Title to be Announced
Following Session is for Neurodegenerative Diseases: New Insights and Therapeutic Opportunities (Z2)
Expanding Mechanisms and Therapeutic Targets for Neurodegenerative Disease
Molecular Mechanisms of Disease in ALS and FTD
Protein-RNA and Stress Granules Dysregulation in ALS
Functional Diversity of Astrocytes
Molecular and Genetic Mechanisms of Myelin Formation and Repair
Talk Title to be Announced
Following Session is for Neurodegenerative Diseases: New Insights and Therapeutic Opportunities (Z2)
NPTX2, Synaptoxicity and Cognitive Dysfunction in AD
Synaptic and Cognitive Dysfunction from Non-fibrillar Tau
Control of ADAM10 α-Secretase Cleavage of Amyloid Precursor Protein by GDE2-RECK
Following Session is for Neurodegenerative Diseases: New Insights and Therapeutic Opportunities (Z2)
Following Session is for Neurodegenerative Diseases: New Insights and Therapeutic Opportunities (Z2)
Registered attendees can view abstracts starting on 05/16/2019
Generation and Use of iPSC-derived Microglia to Study Neurodegenerative Diseases
Neurovascular Interactions: Mechanisms, Imaging, Therapeutics
Registered attendees can view abstracts starting on 05/16/2019
Following Session is for Neurodegenerative Diseases: New Insights and Therapeutic Opportunities (Z2)
Registered attendees can view abstracts starting on 05/16/2019
Keystone Symposia thanks our Sponsor for generously supporting this meeting:
![]() |
|
We gratefully acknowledge additional support from these exhibitors at this conference:
![]() |
|
We gratefully acknowledge additional support for this conference from:
![]() |
|
We appreciate the organizations that provide Keystone Symposia with additional support, such as marketing and advertising:
Click here to view more of these organizations
Special thanks to the following for their support of Keystone Symposia initiatives to increase participation at this meeting by scientists from underrepresented backgrounds:
Click here to view more of these organizations
If your organization is interested in joining these entities in support of Keystone
Symposia, please contact: Sarah Lavicka,
Director of Development, Email: sarahl@keystonesymposia.org, Phone:+1 970-262-2690 Click here for more information on Industry Support and Recognition Opportunities. If you are interested in becoming an advertising/marketing in-kind partner, please contact: Yvonne Psaila, Director, Marketing and Communications, Email: yvonnep@keystonesymposia.org, Phone:+1 970-262-2676 |